mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
0.15 |
0.4 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |